Claritev (CTEV)
NYSEMarket Closed
Claritev Corporation is a healthcare technology, data, and analytics company serving participants in the United States healthcare system. The company’s work centers on a persistent challenge for insurers, employers, healthcare payers, and other clients: understanding medical claims, managing costs, improving payment accuracy, and creating greater transparency around healthcare pricing and reimbursement.
Claritev provides technology-enabled services that combine payment integrity, network-based capabilities, and analytics. Its solutions are designed to help clients review claims, identify billing or reimbursement issues, apply contractual and market-based pricing insights, and support end-to-end cost management. In a healthcare market known for complex billing practices and fragmented data, the company positions itself as an infrastructure partner that helps clients interpret information and make more consistent payment decisions.
The company’s offerings can support several related functions, including payment and revenue integrity, claims cost containment, data-driven decision support, and customized analytics. Rather than relying on a single product, Claritev works across multiple service categories and tailors solutions to client needs. That model reflects the varied requirements of health plans, third-party administrators, employers, and other organizations that face pressure to control medical spending while maintaining access to care.
Claritev operates in a sector shaped by rising healthcare costs, regulatory scrutiny, and increasing demand for transparent, data-supported pricing. Its value proposition depends on combining healthcare domain knowledge with scalable technology and large data assets. For investors, the company represents exposure to the administrative, analytics, and cost-management layer of the U.S. healthcare industry, rather than to direct care delivery or pharmaceutical innovation.
Last updated
- Market Cap
- $631,631,946
- P/E
- —
- P/FCF
- —
- P/S
- 0.64
- Enterprise Value
- $5,389,816,946
- Sector
- Health Care
- Industry
- Health Care Equipment
- Address
- 7900 TYSONS ONE PLACE, MCLEAN, VA, 22102
UnitedHealth Group (UNH) Stock Still Looks Cheap Following Raised 2026 Outlook
UnitedHealth Group (UNH) Faces Wider DOJ Antitrust Probe As Claritev Review Expands
Update: Market Chatter: DOJ Expands Antitrust Probe Into Claritev
CLARITEV STOCKHOLDER ALERT: Bragar Eagel & Squire, P.C. is Investigating Claritev Corporation on Behalf of Claritev Stockholders and Encourages Investors to Contact the Firm
Best Buy downgrade, Dell upgraded: Wall Street's top analyst calls
CTEV INVESTOR ALERT: Kirby McInerney LLP Investigates Potential Claims Involving Claritev Corporation
Sector Update: Healthcare Stocks Advance Late Afternoon
Sector Update: Healthcare Stocks Advance Monday Afternoon
Claritev Q1 Earnings Call Highlights
Claritev Corporation Q1 2026 Earnings Call Summary
Claritev Corporation (CTEV) Reports Q1 Loss, Tops Revenue Estimates
Clover Health Investments, Corp. (CLOV) Meets Q1 Earnings Estimates
Schrodinger, Inc. (SDGR) Reports Q1 Loss, Misses Revenue Estimates
How The Claritev (CTEV) Story Is Shifting As Analysts Trim Targets Yet Stay Positive
Concerns Surrounding AI Pressured Claritev Corp (CTEV)
Claritev Shareholders Are Encouraged to Reach Out to Johnson Fistel for More Information About Potentially Recovering Their Losses
Camping World Shareholders Are Encouraged to Reach Out to Johnson Fistel for More Information About Potentially Recovering Their Losses
Claritev Slides 20% After Selling Stockholders Price 1.5 Mln Share Offering
Claritev Corporation Q3 Loss Decreases
Claritev Corp (CTEV) Bounces to Revenue Growth as Net Loss Shrinks
- Market Cap
Market cap is the total value of a company's shares, calculated by multiplying the stock price by the number of shares outstanding.
- $631,631,946
- Enterprise Value
Enterprise value is the total value of a company, including its market cap, debt, and cash.
- $5,389,816,946
- P/E
P/E ratio compares a company's share price to its earnings per share.
- —
- P/B
P/B ratio compares a company's share price to its book value per share.
- -2.14
- P/S
P/S ratio compares a company's share price to its revenue per share.
- 0.64
- EV / EBITDA
EV/EBITDA measures a company's value compared to its earnings before interest, taxes, depreciation, and amortization.
- 10.9
- EV / Sales
EV/Sales measures a company's value compared to its total revenue.
- 5.42
- EPS
- -16.71
- Dividend Yield
Dividend yield shows how much a company pays in dividends each year compared to its share price.
- 0%
- P/FCF
Price-to-free-cash-flow ratio compares a company's share price to the cash it generates after expenses and investments.
- —
- P/CF
P/CF ratio compares a company's share price to the cash flow it generates from its operations.
- 4.75
- Free Cash Flow
Free cash flow is the cash a company has left after covering operating costs and capital expenses.
- -$17,924,000
- ROE
ROE measures how effectively a company uses shareholders' equity to generate profit.
- 96.11%
- ROA
ROA measures how effectively a company uses its assets to generate profit.
- -5.94%
- Debt / Equity
Debt-to-equity ratio compares a company's total debt to its shareholders' equity.
- -16.2
- Current Ratio
Current ratio measures a company's ability to pay short-term debts using its short-term assets.
- 1
- Quick Ratio
Quick ratio measures a company's ability to pay short-term debts using cash and other easily available assets.
- 1
- Cash
Cash ratio measures a company's ability to cover short-term debts using only cash and cash equivalents.
- 0.06
- Avg Volume
Average volume shows the average number of shares traded over the last 30 trading days, helping indicate liquidity.
- $122,482
- Fundamentals Snapshot Price
Fundamentals snapshot price is the stock price used when calculating the company's financial ratios and metrics.
- 37.27
Income Statement
| Line Item | 2026 Q2 | 2026 Q1 | 2025 Q4 | 2025 Q3 | 2025 Q2 |
|---|---|---|---|---|---|
| Revenue | 257.48M | 244.68M | 246.55M | 245.96M | 241.57M |
| Cost of revenue | 67.67M | 69.08M | 70.09M | 62.06M | 60.82M |
| Gross profit | 189.81M | 175.6M | 176.46M | 183.9M | 180.75M |
| Operating income | 23.72M | 6.68M | 8.67M | 10.07M | 18.4M |
| EBITDA | 134.42M | 117.77M | 120.41M | 122.01M | 129.63M |
| Net income | -59.23M | -73.56M | -80.57M | -69.75M | -62.64M |
| Income taxes | -17.42M | -19.16M | -26.35M | -23.61M | -20.29M |
| Interest expense | -100.25M | -99.54M | -99.41M | -101.23M | -99.75M |
| Other operating expenses | 0 | 0 | 0 | 0 | 0 |
| Total operating expenses | 166.09M | 168.92M | 167.79M | 173.83M | 162.35M |
| Basic EPS | -3.49 | -4.41 | -4.87 | -4.23 | -3.81 |
| Diluted EPS | -3.49 | -4.41 | -4.87 | -4.23 | -3.81 |
Balance Sheet
| Line Item | 2026 Q2 | 2026 Q1 | 2025 Q4 | 2025 Q3 | 2025 Q2 |
|---|---|---|---|---|---|
| Total assets | 4.76B | 4.84B | 4.89B | 4.99B | 5.07B |
| Total liabilities | 5.05B | 5.07B | 5.06B | 5.09B | 5.11B |
| Total equity | -287.84M | -234.41M | -167.18M | -101.84M | -39.91M |
| Cash & equivalents | 14.37M | 21.33M | 16.81M | 39.15M | 56.39M |
| Current assets | 236.42M | 242.27M | 224.37M | 257.46M | 247.14M |
| Current liabilities | 237.51M | 189.56M | 261.36M | 213.32M | 253.14M |
| Accounts payable | 56.67M | 59.18M | 60.46M | 38.93M | 43.43M |
| Receivables | 130.9M | 140.92M | 127.62M | 126.99M | 123.58M |
| Inventories | 0 | 0 | 0 | 0 | 0 |
| Goodwill | 2.41B | 2.41B | 2.41B | 2.4B | 2.4B |
| Long-term debt | 4.66B | 4.7B | 4.58B | 4.62B | 4.61B |
Cash Flow
| Line Item | 2026 Q2 | 2026 Q1 | 2025 Q4 | 2025 Q3 | 2025 Q2 |
|---|---|---|---|---|---|
| Operating cash flow | 92.67M | -45.78M | 66.29M | 19.86M | 61.24M |
| Investing cash flow | -38.08M | -46.77M | -34.66M | -22.87M | -24.62M |
| Financing cash flow | -61.64M | 98.93M | -53.93M | -13.63M | -3.23M |
| Change in cash | -7.05M | 6.39M | -22.3M | -16.64M | 33.39M |
| Net income | -59.23M | -73.56M | -80.57M | -69.75M | -62.64M |
| Kind | Filing | Date | Link |
|---|---|---|---|
| edgar index | 4 — Claritev Corp | View Filing | |
| edgar index | 144 — Claritev Corp | View Filing | |
| form 4 | Form 4 — Misencik Tiffani | View Filing | |
| edgar index | 4 — Claritev Corp | View Filing | |
| edgar index | 144 — Claritev Corp | View Filing | |
| form 4 | Form 4 — Mintz William B. | View Filing | |
| edgar index | 8-K — Claritev Corp | View Filing | |
| edgar index | 10-Q — Claritev Corp | View Filing | |
| edgar index | 4 — Claritev Corp | View Filing | |
| edgar index | 4 — Claritev Corp | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| form 4 | Form 4 — Garis Douglas Michael | View Filing | |
| form 4 | Form 4 — Garis Douglas Michael | View Filing | |
| form 4 | Form 4 — Garis Douglas Michael | View Filing | |
| form 4 | Form 4 — Garis Douglas Michael | View Filing | |
| form 4 | Form 4 — Garis Douglas Michael | View Filing | |
| form 4 | Form 4 — Mintz William B. | View Filing | |
| edgar index | 8-K — Claritev Corp | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | 4 — Claritev Corp | View Filing | |
| form 4 | Form 4 — Albinson Brock | View Filing | |
| edgar index | 8-K — Claritev Corp | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | 4 — Claritev Corp | View Filing | |
| form 4 | Form 4 — Carol Nutter | View Filing | |
| edgar index | 4 — Claritev Corp | View Filing | |
| edgar index | 4 — Claritev Corp | View Filing | |
| edgar index | 4 — Claritev Corp | View Filing | |
| form 4 | Form 4 — Prince John Michael | View Filing | |
| edgar index | 8-K — Claritev Corp | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| form 4 | Form 4 — Kim Michael | View Filing | |
| form 4 | Form 4 — Dalton Travis | View Filing | |
| form 4 | Form 4 — Dalton Travis | View Filing | |
| form 4 | Form 4 — Dalton Travis | View Filing | |
| edgar index | 8-K — Claritev Corp | View Filing | |
| edgar index | 10-Q — Claritev Corp | View Filing | |
| edgar index | S-8 — Claritev Corp | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | 4 — Claritev Corp | View Filing | |
| edgar index | 4 — Claritev Corp | View Filing | |
| edgar index | 4 — Claritev Corp | View Filing | |
| edgar index | 4 — Claritev Corp | View Filing | |
| edgar index | 4 — Claritev Corp | View Filing | |
| edgar index | 4 — Claritev Corp | View Filing | |
| edgar index | 4 — Claritev Corp | View Filing | |
| edgar index | 8-K — Claritev Corp | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| form 4 | Form 4 — HARRIS C MARTIN | View Filing | |
| form 4 | Form 4 — Colaluca Anthony Jr | View Filing | |
| form 4 | Form 4 — Colaluca Anthony Jr | View Filing | |
| form 4 | Form 4 — Clarke Richard A | View Filing | |
| form 4 | Form 4 — Klein Michael Stuart | View Filing | |
| form 4 | Form 4 — Klein Michael Stuart | View Filing | |
| form 4 | Form 4 — Klapstein Julie D | View Filing | |
| form 4 | Form 4 — Prince John Michael | View Filing | |
| form 4 | Form 4 — Kap Jason Lamar | View Filing | |
| edgar index | 4 — Claritev Corp | View Filing | |
| form 4 | Form 4 — Albinson Brock | View Filing | |
| edgar index | DEF 14A — Claritev Corp | View Filing | |
| edgar index | DEFA14A — Claritev Corp | View Filing | |
| edgar index | ARS — Claritev Corp | View Filing | |
| edgar index | 8-K — Claritev Corp | View Filing | |
| edgar index | 4 — Claritev Corp | View Filing | |
| edgar index | 4 — Claritev Corp | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| form 4 | Form 4 — Garis Douglas Michael | View Filing | |
| form 4 | Form 4 — Garis Douglas Michael | View Filing | |
| form 4 | Form 4 — Garis Douglas Michael | View Filing | |
| form 4 | Form 4 — Garis Douglas Michael | View Filing | |
| form 4 | Form 4 — Garis Douglas Michael | View Filing | |
| form 4 | Form 4 — Kim Michael | View Filing | |
| edgar index | 4 — Claritev Corp | View Filing | |
| edgar index | 4 — Claritev Corp | View Filing | |
| edgar index | 4 — Claritev Corp | View Filing |